Lighthouse Pharmaceuticals Reports New Evidence that Gingipain Inhibition Benefits Neuropsychiatric Symptoms and Reduces Caregiver Distress in P. gingivalis-Positive Alzheimer’s Disease at AAIC 2026

Author: Lighthouse Pharmaceuticals

Posted Date: